Opioid treatment gap

Medicare doesn’t cover most-effective medication

Associated Press

One in three older Americans with Medicare drug coverage is prescribed opioid painkillers, but for those who develop a dangerous addiction, there is one treatment Medicare won’t cover: methadone.

Methadone is the oldest and, experts say, the most effective of the three approved medications used to treat opioid addiction. It eases cravings without an intense high, allowing patients to work with counselors to rebuild their lives.

Federal money is flowing to states to open new methadone clinics through the 21st Century Cures Act, but despite the nation’s deepening opioid crisis, the Medicare drug program for the elderly covers methadone only when prescribed for pain.

Joseph Purvis, a former heroin and prescription painkiller user, said he went into a depressive tailspin because he initially feared he might have to stop methadone treatment when he went on Medicare at 65.

“I was terrified that I might have to leave the program. There’s no way I wanted to go back to addiction on the streets,” said Purvis, 66, of Gaithersburg, Md.

Methadone doesn’t meet the requirement of Medicare’s Part D drug program because it can’t be dispensed in a retail pharmacy.

Instead, in the highly regulated methadone system, patients first are assessed by a doctor, then show up daily at federally certified methadone clinics to take their doses of the pink liquid. Or, like Purvis in Maryland, they prove through repeated urine screens that they have earned the right to weekly take-home doses.

In Congress, legislation has been introduced in the House and Senate, and a White House commission on the opioid epidemic also recommended the change.

The epidemic is “affecting all populations, including our seniors,” said Rep. George Holding, R-N.C., a sponsor of the House bill. “Medicare beneficiaries have among the highest and fastest-growing rate of opioid use disorder, but they don’t currently have coverage for the most- effective treatment.”

“We have a sacred responsibility to find solutions that help everyone who may be affected,” said Sen. Bob Casey, D-Pa., ranking member of the Special Committee on Aging and lead sponsor of the Senate bill.

An estimated 300,000 Medicare patients have been diagnosed with opioid addiction, and health officials estimate nearly 90,000 are at high risk for opioid misuse or overdose.

Buprenorphine, a more expensive and slightly less regulated treatment drug, is covered by Medicare, but few doctors who accept new Medicare patients have obtained federal waivers to prescribe it. A recent study of Medicare claims found prescriptions for buprenorphine for only 81,000 patients.

More evidence that the crisis affects seniors: Opioid overdoses killed 1,354 Americans age 65 and older in 2016, about 3 percent of the 42,000 opioid overdoses that year.

Medicare’s policy means clinics often scramble to keep older patients in treatment if they’ve had commercial insurance that covered their care before turning 65, said counselor Angela Caldwell of Montgomery Recovery Services in Rockville, Md.

A national organization for methadone clinics says the clinics now have 25,000 Medicare beneficiaries who are either paying out of pocket (about $80 per week) or getting care through state-run Medicaid or block grant programs.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, thinks more people would seek methadone treatment if Medicare covered it.